Indication: Regular treatment of asthma where use of a combination product (long-acting β2 agonist and inhaled corticosteroid) is appropriate:

• Patients not adequately controlled with inhaled corticosteroids and as needed' inhaled short- acting β2 agonist
• Patients already adequately controlled on both inhaled corticosteroid and long-acting β2 agonist

Composition: Fluticasone 250mcg, Salmeterol 25mcg

Pack Size: 120 doses

Form: Inhalation Suspension

Manufacturer: Berg life SA

Manufacturing Country: Tunisia

Registration Number: 20314/1